Search clinical trials for: Osteoporosis in male with Prostate Cancer
Total 469543 results
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate Cancer | OsteoporosisUnited States, Canada
-
AmgenCompletedCancer | Cataract | Prostate Cancer | Osteoporosis | Osteopenia | Low Bone Mineral DensityUnited States, Canada, Czechia, Poland, Russian Federation, Slovakia, Hungary, South Africa, Greece, Bulgaria, France, Ukraine, Australia, Latvia, India, Slovenia, New Zealand, Mexico
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate Cancer | OsteoporosisUnited States, Canada
-
AHS Cancer Control AlbertaCross Cancer InstituteCompletedProstate Cancer | OsteoporosisCanada
-
OHSU Knight Cancer InstituteLance Armstrong FoundationCompletedOsteoporosis | Prostatic NeoplasmUnited States
-
City of Hope Medical CenterCompletedPilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate CancerBreast Cancer | Prostate Cancer | Osteoporosis | OsteopeniaUnited States
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedProstatic NeoplasmsUnited States
-
GTxCompletedProstate Cancer | Osteoporosis | FracturesUnited States, Mexico
-
University of RochesterNational Cancer Institute (NCI)CompletedProstate Cancer | OsteoporosisUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)CompletedProstate Cancer | OsteoporosisUnited States
-
SanofiCompletedProstate Cancer | OsteoporosisIsrael
-
National Institute of Diabetes and Digestive and...CompletedProstate Cancer | Osteoporosis | HypogonadismUnited States
-
University Health Network, TorontoRecruiting
-
Maria Sklodowska-Curie National Research Institute...Not yet recruiting
-
Uppsala UniversitySahlgrenska University Hospital, Sweden; University Hospital, Umeå; Uppsala University... and other collaboratorsNot yet recruiting
-
Canadian Cancer Trials GroupCanadian Institutes of Health Research (CIHR)Not yet recruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate Cancer
-
Peking University Third HospitalBayerNot yet recruiting
-
Paul ViscuseNot yet recruitingMetastatic Prostate Cancer | Castrate Sensitive Prostate CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Not yet recruitingMalignant Solid Neoplasm | Breast Carcinoma | Metastatic Prostate Carcinoma | Ovarian Carcinoma | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Pancreatic Exocrine Neoplasm | Stage IVB Prostate Cancer American Joint Committee on Cancer v8United States
-
First Affiliated Hospital of Chongqing Medical...RecruitingPSMA | Prostate Cancer Stage | SPECTChina
-
Fusion Pharmaceuticals Inc.RecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Adam S. Kibel, MDNational Cancer Institute (NCI)RecruitingProstate Cancer | Polygenic Risk ScoreUnited States
-
858 Therapeutics, Inc.RecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Advanced or Metastatic Solid Tumors | ER+ Breast Cancer | Castrate Resistant Prostate Cancer | BRCA MutationUnited States
-
Debiopharm International SARecruitingProstate CancerUnited States
-
Qian QinJanssen, LP; UT Southwestern Comprehensive Cancer CenterNot yet recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | BRIP1 Gene Mutation | PALB2 Gene Mutation | CHEK2 Gene Mutation | FANCA Gene Mutation | RAD51B Gene Mutation | RAD54L Gene Mutation | Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | Deleterious HRR Gene Mutation
-
Robert Bok, MD, PhDNational Cancer Institute (NCI)Not yet recruitingProstate CancerUnited States
-
University Hospital, EssenBristol-Myers Squibb; Advanced Accelerator ApplicationsNot yet recruitingVery High Risk Prostate CarcinomaGermany
-
Mayo ClinicNot yet recruitingLocalized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States
-
The First Affiliated Hospital of Xiamen UniversityRecruiting
-
AstraZenecaMerck Sharp & Dohme LLCRecruitingMetastatic Castration-resistant Prostate CancerGermany
-
Novartis PharmaceuticalsNot yet recruitingMetastatic Neuroendocrine Prostate Cancer
-
The First Affiliated Hospital of Xiamen UniversityRecruitingMetastatic Castration-resistant Prostate Cancer, mCRPCChina
-
Mayo ClinicRecruitingProstate Adenocarcinoma | Oligometastatic Prostate CarcinomaUnited States
-
M.D. Anderson Cancer CenterNot yet recruitingAdvanced Prostate CancerUnited States
-
St. Mary's Research Center, CanadaSunnybrook Health Sciences Centre; University of British Columbia; McGill University and other collaboratorsNot yet recruitingAnxiety | Cancer of the ProstateCanada
-
Chinese University of Hong KongNot yet recruiting
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstatic Neoplasms, Castration-ResistantIsrael, Taiwan, Australia
-
The First Affiliated Hospital with Nanjing Medical...RecruitingMetastatic Prostate Cancer | Therapy, Directly ObservedChina
-
Memorial Sloan Kettering Cancer CenterRecruitingProstate CancerUnited States
-
Ashutosh Kumar TewariOncovir, Inc.RecruitingProstate Cancer Patients on Active SurveillanceUnited States
-
University Hospital, Basel, SwitzerlandNot yet recruitingCastration-resistant Prostate CancerSwitzerland
-
Fondazione del Piemonte per l'OncologiaRecruiting
-
BayerNot yet recruitingNon-metastatic Castration-resistant Prostate Cancer | Metastatic Hormone-sensitive Prostate CancerKorea, Republic of
-
Ohio State University Comprehensive Cancer CenterPfizer; Myovant Sciences GmbH; Sumitomo Pharmaceuticals AmericaNot yet recruitingProstate Adenocarcinoma | Stage IIC Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8United States
-
University Hospital FreiburgGerman Federal Ministry of Education and ResearchRecruiting
-
AbbVieRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Israel
-
Pedro Barata, MD, MScESSA Pharma Inc.Not yet recruitingProstate Cancer | Prostate Adenocarcinoma | Metastatic Hormone-sensitive Prostate Cancer (mHSPC)United States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Recruiting